TNFRSF9 and neoplasm: Hypomethylation-mediated GATA6 activation induced aberrant CD137 ligand expression and promoted multiple tumor-driving pathways in the proliferation of CTCL cell lines and tumor formation in NSG and C57BL/6 mouse models51.